Diabetes Care and Treatment

contact@imedpub.com

Articles On Glycemic Control

Glycemic control remains a delicate balancing act. The diabetic patient is tasked with maintaining euglycemic blood glucose levels, a goal requiring education, decision strategies, volitional control, and thus the wisdom to avoid hyper- and hypoglycemia, with the latter defined as plasma glucose but ∼60 mg/dl. Glucose levels must be controlled continuously and without holidays. Failure to require care of euglycemia results from biological factors and psychosocial factors including overmedication and/or inappropriate choices regarding food, drink, and, in certain cases, exercise.
Diabetic patients, especially those treated with insulin, are at risk for developing hypoglycemia. Treatment, even with oral agents like sulfonylureas, increases this risk. Asymptomatic episodes of hypoglycemia may constitute up to 10% of a 24-h period in diabetic patients. Individuals with type 1 diabetes average 43 symptomatic episodes annually; insulin-treated individuals with type 2 diabetes average 16 episodes. As for severe hypoglycemic episodes, patients with type 1 diabetes experience up to 2 episodes annually, whereas patients with type 2 diabetes experience about one episode over 5 years. The risk increases with a history of hypoglycemia and an increased number of years of insulin treatment.
Hypoglycemia deprives the brain of the constant supply of glucose needed for energy. Such low levels of blood glucose are sensed by the ventromedial hypothalamus. In turn, a counter regulatory hormonal cascade is activated to rapidly restore euglycemia that begins with inhibition of insulin secretion. Thereafter, the release of glucagon and epinephrine elevates endogenous glucose production through increased hepatic glycogenolysis and gluconeogenesis, as well as renal gluconeogenesis. Growth hormone and cortisol are slow-acting adjustments to prolonged hypoglycaemia. Hypoglycemia may promote oxidative stress and neuronal necrobiosis , primarily as a consequence of neuronal NADPH oxidase activation and extracellular zinc release during glucose reperfusion. Thus, heightened glucose concentrations during reperfusion can cause necrobiosis . Counter regulatory responses also stimulate the sympathetic autonomic nervous system, resulting in symptoms of sweating, trembling, anxiety, hunger, and nervousness. Deprivation of glucose triggers neuroglycopenic symptoms, including confusion and irritability.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards Nomination
Open Access Journals